gamma-glutamylvaline: improves the bitter taste of valine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
gamma-Glu-Val : A glutamyl-L-amino acid that is the N-(L-gamma-glutamyl) derivative of L-leucine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 7015683 |
| CHEBI ID | 68848 |
| SCHEMBL ID | 2566460 |
| MeSH ID | M0462369 |
| Synonym |
|---|
| gamma-glutamyl-valine |
| l-gamma-glutamyl-l-valine |
| (2s)-2-amino-5-{[(1s)-1-carboxy-2-methylpropyl]amino}-5-oxopentanoic acid |
| l-gamma-glu-l-val |
| CHEBI:68848 |
| gamma-glutamylvaline |
| gamma-glu-val |
| 2746-34-1 |
| h-glu(val-oh)-oh |
| SCHEMBL2566460 |
| mfcd00055783 |
| AKOS030573507 |
| g-glu-val |
| Q27137212 |
| h-gamma-glu-val-oh |
| (2s)-2-amino-5-[[(1s)-1-carboxy-2-methylpropyl]amino]-5-oxopentanoic acid |
| -l-glutamyl-l-valine |
| -glutamylvaline |
| ggluval |
| gamma glutamyl l valine |
| g glu val |
| h gglu val oh |
| gamma-glutamyl-l-valine |
| DTXSID801316652 |
| Z3247556272 |
| Role | Description |
|---|---|
| human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| glutamyl-L-amino acid | A dipeptide in which one of the amino acid residues is glutamine. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||